FDA Commissioner Nomination Hearing Scheduled By Senate Health Committee
This article was originally published in The Pink Sheet Daily
Executive Summary
Nomination of FDA Acting Commissioner von Eschenbach to the post will be reviewed Aug. 1, although a vote is not anticipated.